CA
NZ
UK
AU
IND
US
HCW Biologics Inc. filed a current report on November 5, 2026, disclosing that it entered into a Notes Purchase Agreement with Streeterville Capital, LLC on November 3, 2026, providing for two secured promissory notes totaling $10.2 million in original principal.
Immunic, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing that the company hosted a Progressive Multiple Sclerosis Research and Development Day webinar and attaching the accompanying presentation as an exhibit.
Kartoon Studios, Inc. filed a current report on Form 8-K on November 5, 2026, disclosing that its subsidiary-sponsored special purpose acquisition company, Kartoon Studios Acquisition Corp., had submitted a Form S-1 registration statement with the U.S. Securities and Exchange Commission in connection with a …
Myriad Genetics, Inc. filed a Form 8-K on November 5, 2026, disclosing that it detected unauthorized access within its information technology network environment on November 2, 2026.
MetaVia Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing positive interim clinical trial data and an updated corporate presentation.
Dropbox, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing a definitive agreement to acquire Tigris Data Inc. for approximately $350 million in cash, signed on November 3, 2026, and announcing the launch of a new offering called DBX Agent …
Construction Partners, Inc. filed a Form 8-K on November 5, 2026, disclosing preliminary financial results for the fiscal year ended September 30, 2026, a preliminary outlook for the fiscal year ending September 30, 2027, and the completion of an acquisition transaction announced on November …
Tractor Supply Company filed a Form 8-K with the SEC on November 5, 2026, announcing the declaration of a cash dividend of $0.24 per share of common stock, payable December 8, 2026, to stockholders of record as of the close of business on November …
Chatham Lodging Trust filed a Form 8-K with the SEC on November 5, 2026, announcing the release of its results of operations for the three months ended September 30, 2026.
AIM ImmunoTech Inc. filed a Form 8-K with the SEC on November 5, 2026, furnishing a corporate presentation titled "The Ampligen Opportunity" and an accompanying press release under Regulation FD.
Please wait processing your request...